Mark Jeng
Impact in
- Virology top 10%
- HIV Research and Treatment
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- Virology 2
- HIV Research and Treatment 2
- Co-authors
- Mélanie Ott (3 shared papers)Jeffrey R. Johnson (2 shared papers)Nevan J. Krogan (2 shared papers)Philip A. Hull (2 shared papers)Hye‐Sook Kwon (1 shared paper)Herbert G. Kasler (1 shared paper)Mingjian Fei (1 shared paper)Eric Verdin (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Geriatric Oncology (1 paper)Cell Host & Microbe (1 paper)Annals of Oncology (1 paper)Journal of Investigative Dermatology (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Mark Jeng
8 papers receiving 291 citations
Peers
Comparison fields: 5 of 46
- Virology 64
- Geriatrics and Gerontology 21
- Dermatology 34
- Immunology 80
- Epidemiology 102
Countries citing papers authored by Mark Jeng
This map shows the geographic impact of Mark Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jeng more than expected).
Fields of papers citing papers by Mark Jeng
This network shows the impact of papers produced by Mark Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jeng. The network helps show where Mark Jeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Jeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 99 | |
| 2 | 2017 | 81 | |
| 3 | 2018 | 80 | |
| 4 | 2015 | 18 | |
| 5 | 2018 | 12 | |
| 6 | 2025 | 1 | |
| 7 | 2025 | 1 | |
| 8 | 2025 | 1 | |
| 9 | 2025 | 0 |
About Mark Jeng
Mark Jeng is a scholar working on Molecular Biology, Virology, Pulmonary and Respiratory Medicine, Immunology and Geriatrics and Gerontology, having authored 9 papers that have together received 293 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (2 papers), Protein Degradation and Inhibitors (2 papers), Lung Cancer Treatments and Mutations (2 papers), HIV Research and Treatment (2 papers), Immune Cell Function and Interaction (2 papers), Acute Myeloid Leukemia Research (1 paper), Immunotherapy and Immune Responses (1 paper) and Telomeres, Telomerase, and Senescence (1 paper). The work is most often cited by research in Virology (64 citations), Geriatrics and Gerontology (21 citations), Dermatology (34 citations), Immunology (80 citations) and Epidemiology (102 citations). Mark Jeng has collaborated with scholars based in United States and Germany. Frequent co-authors include Mélanie Ott, Jeffrey R. Johnson, Nevan J. Krogan, Philip A. Hull, Hye‐Sook Kwon, Herbert G. Kasler, Mingjian Fei, Eric Verdin, Chia-Lin Tsou and David E. Gordon. Their work appears in journals such as Journal of Clinical Oncology, Journal of Geriatric Oncology, Cell Host & Microbe, Annals of Oncology and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.